A phase I study of Triapine [OCX 0191] in combination with radiation therapy in locally advanced pancreas cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs OCX 191 (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 04 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Jul 2012 Planned end date changed from 1 Aug 2007 to 1 Jan 2100 as reported by ClinicalTrials.gov
- 25 Feb 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov, last updated 25-2-2009.